The Toro Company (NYSE:TTC) will release earnings results for the fourth quarter before the opening bell on Wednesday, Dec. 17. Analysts expect the Bloomington, Minnesota-based company to report quarterly earnings at 88 cents per share, down from 95 cents per…
Featured
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Morgan Stanley raised Hershey Co (NYSE:HSY) price target from $195…
U.S. stock futures are up early Monday morning, following a mixed week that saw rotation out of expensive tech stocks in favor of value, despite the third consecutive interest rate cut on Wednesday. Investors on Monday will be eagerly awaiting…
Avalon GloboCare Corp. (NASDAQ:ALBT) announced Monday that it has acquired RPM Interactive, Inc., a generative artificial intelligence software company, through an all-stock transaction. The acquisition aims to expand Avalon's digital marketing capabilities and strengthen its balance sheet. The deal includes…
As of Dec. 15, 2025, two stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Cantor Fitzgerald analyst Kristen Kluska initiated coverage on DBV…
Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLY) State Street Consumer Discretionary Select Sector SPDR ETF 121.59 0.89 0.73 4.7K (NYSE:XLF) State Street Financial Select Sector SPDR ETF 55.26 0.31 0.56 48.7K (NYSE:XLU) State Street Utilities Select Sector…
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Monday. Shares of argenx SE – ADR (NASDAQ:ARGX) fell sharply in pre-market trading after the company discontinued its Phase 3 UplighTED studies of efgartigimod…
On Monday, Sanofi SA (NASDAQ:SNY) announced results from the PERSEUS phase 3 study of tolebrutinib compared to placebo for primary progressive multiple sclerosis (PPMS). Multiple sclerosis is an autoimmune disease resulting in damage to myelin, which is the insulating cover…
Lennar Corporation (NYSE:LEN) will release earnings results for the fourth quarter after the closing bell on Tuesday. Analysts expect the company to report quarterly earnings at $2.18 per share, down from $4.03 per share in the year-ago period. The consensus…

